Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear Glucocorticoid Injection for Sudden Sensorineural Hearing Loss
NCT07814677Phase 2Not yet recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in sudden sensorineural hearing loss (SSHL), sponsored by Eye and ENT Hospital of Fudan University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT07814677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814677.